BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1198326)

  • 21. Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity.
    Winn LM; Wells PG
    Mol Pharmacol; 1995 Jul; 48(1):112-20. PubMed ID: 7623765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats.
    Hays SM; Elswick BA; Blumenthal GM; Welsch F; Conolly RB; Gargas ML
    Toxicol Appl Pharmacol; 2000 Feb; 163(1):67-74. PubMed ID: 10662606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in craniofacial growth induced by isotretinoin (13-cis-retinoic acid) in mouse whole embryo and primary mesenchymal cell culture.
    Watanabe T; Goulding EH; Pratt RM
    J Craniofac Genet Dev Biol; 1988; 8(1):21-33. PubMed ID: 3209676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth retardation and cell death in mouse embryos following exposure to the teratogen bromodeoxyuridine.
    Packard DS; Skalko RG; Menzies RA
    Exp Mol Pathol; 1974 Dec; 21(3):351-62. PubMed ID: 4430343
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts.
    Kinsella TJ; Glennon MC; Kunugi KA; Lindstrom MJ
    Clin Cancer Res; 1996 Jun; 2(6):981-9. PubMed ID: 9816259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorportaiton of thymidine and its analogue, bromodeoxyuridine, into embryos and maternal tissues of the mouse.
    Packard DS; Menzies RA; Skalko RG
    Differentiation; 1973 Dec; 1(6):397-404. PubMed ID: 4802502
    [No Abstract]   [Full Text] [Related]  

  • 27. Cadmium uptake and distribution in mouse embryos following maternal exposure during the organogenic period: a scintillation and autoradiographic study.
    Christley J; Webster WS
    Teratology; 1983 Jun; 27(3):305-12. PubMed ID: 6879454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teratogenicity of 3-hydroxynorvaline in chicken and mouse embryos.
    Louw R; Potgieter HC; Vorster W
    Amino Acids; 2005 Nov; 29(3):207-12. PubMed ID: 16082502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinamides: hydrolytic conversion of retinoylglycine to retinoic acid in pregnant mice contributes to teratogenicity.
    Kochhar DM; Shealy YF; Penner JD; Jiang H
    Teratology; 1992 Feb; 45(2):175-85. PubMed ID: 1615427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Teratogenic effects of valproic acid and diphenylhydantoin on mouse embryos in culture.
    Bruckner A; Lee YJ; O'Shea KS; Henneberry RC
    Teratology; 1983 Feb; 27(1):29-42. PubMed ID: 6405496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The embryotoxicity of gossypol.
    Beaudoin AR
    Teratology; 1985 Oct; 32(2):251-7. PubMed ID: 4049283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of 5-bromodeoxyuridine on fusion of the cranial neural folds in the mouse embryo.
    Bannigan JG
    Teratology; 1985 Oct; 32(2):229-39. PubMed ID: 4049281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Teratogen-induced distortions in the classical NF-kappaB activation pathway: correlation with the ability of embryos to survive teratogenic stress.
    Molotski N; Savion S; Gerchikov N; Fein A; Toder V; Torchinsky A
    Toxicol Appl Pharmacol; 2008 Jun; 229(2):197-205. PubMed ID: 18395765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible mechanism of congenital malformations induced by exposure of mouse preimplantation embryos to mitomycin C.
    Nagao T; Saitoh Y; Yoshimura S
    Teratology; 2000 Apr; 61(4):248-61. PubMed ID: 10716743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal toxicokinetics, metabolism, and embryo exposure following a teratogenic dosing regimen with 13-cis-retinoic acid (isotretinoin) in the cynomolgus monkey.
    Hummler H; Hendrickx AG; Nau H
    Teratology; 1994 Sep; 50(3):184-93. PubMed ID: 7871482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Placental transfer and developmental effects of 9-cis retinoic acid in mice.
    Kochhar DM; Jiang H; Penner JD; Heyman RA
    Teratology; 1995 Apr; 51(4):257-65. PubMed ID: 7570368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blocking of the placental immune-modulatory ferritin activates Th1 type cytokines and affects placenta development, fetal growth and the pregnancy outcome.
    Nahum R; Brenner O; Zahalka MA; Traub L; Quintana F; Moroz C
    Hum Reprod; 2004 Mar; 19(3):715-22. PubMed ID: 14998975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Teratogenic effects of 9-hydroxy-ellipticine in mouse embryo].
    Cros S; Raynaud A
    C R Seances Acad Sci III; 1982 Oct; 295(7):465-70. PubMed ID: 6819062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of 5-fluorouracil on [3H]nucleoside incorporation into the DNA of mouse embryos and maternal tissues.
    Skalko RG; Jacobs DM
    Exp Mol Pathol; 1978 Dec; 29(3):303-15. PubMed ID: 720542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.